Zhongzhi Pharmaceutical Holdings Bilan de santé
Santé financière contrôle des critères 5/6
Zhongzhi Pharmaceutical Holdings possède un total de capitaux propres de CN¥1.1B et une dette totale de CN¥74.6M, ce qui porte son ratio d'endettement à 6.7%. Son actif total et son passif total sont CN¥2.0B et de CN¥850.0M. L'EBIT de Zhongzhi Pharmaceutical Holdings est CN¥107.6M ce qui fait que son ratio de couverture des intérêts 42.8. Elle dispose de liquidités et de placements à court terme de CN¥198.9M.
Informations clés
6.7%
Ratio d'endettement
CN¥74.57m
Dette
Ratio de couverture des intérêts | 42.8x |
Argent liquide | CN¥198.92m |
Fonds propres | CN¥1.11b |
Total du passif | CN¥850.02m |
Total des actifs | CN¥1.96b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Recent updates
Little Excitement Around Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Earnings As Shares Take 26% Pounding
Aug 22Calculating The Intrinsic Value Of Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)
Jun 19Most Shareholders Will Probably Agree With Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) CEO Compensation
May 10Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
May 05Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Reducing Its Dividend To CN¥0.03
Apr 21Zhongzhi Pharmaceutical Holdings Limited's (HKG:3737) Prospects Need A Boost To Lift Shares
Feb 01These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
May 24Is Zhongzhi Pharmaceutical Holdings (HKG:3737) A Risky Investment?
Aug 26Zhongzhi Pharmaceutical Holdings (HKG:3737) Has A Pretty Healthy Balance Sheet
Apr 28These 4 Measures Indicate That Zhongzhi Pharmaceutical Holdings (HKG:3737) Is Using Debt Reasonably Well
Jun 11Investors Met With Slowing Returns on Capital At Zhongzhi Pharmaceutical Holdings (HKG:3737)
May 06Zhongzhi Pharmaceutical Holdings (HKG:3737) Strong Profits May Be Masking Some Underlying Issues
Apr 21Do Zhongzhi Pharmaceutical Holdings's (HKG:3737) Earnings Warrant Your Attention?
Mar 29The Zhongzhi Pharmaceutical Holdings (HKG:3737) Share Price Has Gained 50% And Shareholders Are Hoping For More
Mar 05Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Feb 15What Is The Ownership Structure Like For Zhongzhi Pharmaceutical Holdings Limited (HKG:3737)?
Jan 14Would Zhongzhi Pharmaceutical Holdings Limited (HKG:3737) Be Valuable To Income Investors?
Dec 27If You Like EPS Growth Then Check Out Zhongzhi Pharmaceutical Holdings (HKG:3737) Before It's Too Late
Dec 14Did You Miss Zhongzhi Pharmaceutical Holdings' (HKG:3737) 31% Share Price Gain?
Nov 30Is Zhongzhi Pharmaceutical Holdings Limited's(HKG:3737) Recent Stock Performance Tethered To Its Strong Fundamentals?
Nov 17Analyse de la situation financière
Passif à court terme: Les actifs à court terme de 3737 ( CN¥976.9M ) dépassent ses passifs à court terme ( CN¥700.2M ).
Passif à long terme: Les actifs à court terme de 3737 ( CN¥976.9M ) dépassent ses passifs à long terme ( CN¥149.8M ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 3737 dispose de plus de liquidités que de sa dette totale.
Réduire la dette: Le ratio d'endettement de 3737 est passé de 0% à 6.7% au cours des 5 dernières années.
Couverture de la dette: La dette de 3737 est bien couverte par le flux de trésorerie opérationnel ( 226.2% ).
Couverture des intérêts: Les paiements d'intérêts de 3737 sur sa dette sont bien couverts par l'EBIT ( 42.8 x couverture).